Biotech2 hours ago
Abivax Emerges as Prime Takeover Target in Booming IBD Market
The inflammatory bowel disease market is rapidly growing, driven by unmet patient needs despite existing therapies. Major pharma acquisitions highlight strong demand for innovative treatments. Abivax’s...